When most people with type 1 diabetes (T1D) think about hormones, insulin is usually the first one that comes to mind—people with T1D use it daily to survive. But it takes more than just insulin to regulate blood-glucose levels. Hormones act as chemical messengers in the human body—they are released by a cell, organ, or […]
JDRF and Amylin are enthusiastic about the potential of metreleptin to help improve blood glucose control in people with type 1 diabetes. A successful outcome in the metreleptin study would likely lead to studies with larger numbers of people and the development of alternative treatments to using medical insulin alone.